A variety of statistical issues which arise in the analysis of tumorigenesis assay data are reviewed. Tumor acceleration appeared as a possibility in the Red Dye 40 situation and that phenomenon is discussed. Experimental design considerations covered include sex, cage locations, and whether there is complete randomization, or whether littermates are stratified across doses, or whether, as in multigeneration studies, all littermates are treated alike. Whichever, the statistical analysis should be appropriate. Statistical techniques must take into account the time-to-response aspect in the detection of palpable tumors along with the complication of censored observation due to interim mortality. A logrank technique for accomplishing this must be further adjusted so as to handle tumors detectable only on necropsy. Dosage effects may be sought in a variety of ways, including alternative procedures for identifying progressive dosage effects. Separate analyses may be conducted for separate tumor sites or types, introducing a multiple-testing aspect. Because of the sparseness of data for many individual tumor sites, the usual multiple-testing procedures have to be modified. Statistical analysis, however, is only a guide to the careful interpretation of results, and the need to take action as a result of that interpretation remains.
[1]
Mantel Nathan,et al.
Safety" testing of carcinogenic agents.
,
1961
.
[2]
Nathan Mantel,et al.
Chi-square tests with one degree of freedom
,
1963
.
[3]
J. Peto,et al.
Asymptotically Efficient Rank Invariant Test Procedures
,
1972
.
[4]
W. Haenszel,et al.
Statistical aspects of the analysis of data from retrospective studies of disease.
,
1959,
Journal of the National Cancer Institute.
[5]
D. Byar,et al.
Applications of the Mantel-Haenszel statistic to the comparison of survival distributions.
,
1977,
Biometrics.
[6]
N. Mantel,et al.
Use of logrank scores in the analysis of litter-matched data on time to tumor appearance.
,
1979,
Cancer Research.
[7]
J. Tukey,et al.
An improved Mantel-Bryan procedure for "safety" testing of carcinogens.
,
1975,
Cancer research.
[8]
N. Mantel.
Evaluation of survival data and two new rank order statistics arising in its consideration.
,
1966,
Cancer chemotherapy reports.
[9]
T. Fears,et al.
False-positive and false-negative rates for carcinogenicity screens.
,
1977,
Cancer research.
[10]
R Peto,et al.
Editorial: Guidelines on the analysis of tumour rates and death rates in experimental animals.
,
1974,
British Journal of Cancer.